StockData
Freenome, Inc. logo

Freenome, Inc. (FRNM) stock

FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.82−0.27 (-2.68%)

Close on Nov 17, 2026Market cap $1.09BP/E –Yield –

Freenome cash

Cash and short-term investments held at the end of each period.

Freenome's cash was $180.38M at Sep 30, 2026. For fiscal 2025 it was $78.56M, up 3.1% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.56M+3.1%
FY2024Dec 31, 2024$76.17M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$180.38M+143.8%
Q2 FY2026Jun 30, 2026$437.37K-67.5%
Q1 FY2026Mar 31, 2026$567.18K-52.4%
Q4 FY2025Dec 31, 2025$78.56M+3.1%
Q3 FY2025Sep 30, 2025$73.98M+6017.1%
Q2 FY2025Jun 30, 2025$1.34M+4.5%
Q1 FY2025Mar 31, 2025$1.19M–
Q4 FY2024Dec 31, 2024$76.17M–
Q3 FY2024Sep 30, 2024$1.21M–
Q2 FY2024Jun 30, 2024$1.29M–
Q1 FY2024Mar 31, 2024$0–

More Freenome figures

See a number that looks wrong?